53. Sjogren syndrome Clinical trials / Disease details
Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000004237 | 2013/03/31 | 19/09/2010 | Efficacy and safety of mizoribine for patients with Sjogren's syndrome in pediatric age | Efficacy and safety of mizoribine for patients with Sjogren's syndrome in pediatric age - Mizoribine for Sjogren's syndrome in pediatric age | Sjogren's syndrome in pediatric age | Mizoribine 10 mg/kg (up to 500 mg) will be administered once daily twice a week. | Graduate School of Medicine, Chiba University | NULL | Complete: follow-up complete | 10years-old | 20years-old | Male and Female | 5 | Phase 2 | Japan |